AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
METHOCARBAMOL + PARACETAMOL
12 registrations across 5 African markets— 12 active
Markets with METHOCARBAMOL + PARACETAMOL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Distem tablets Tablet | 🇰🇪Kenya | FAES FARMA, S.A. | active | Jun 2028 |
| Dorbaxin Forte Tablets** Tablet | 🇳🇬Nigeria | Xcel Pharmaceutical Limited | active | Oct 2027 |
| METHOCARBAMOL +
PARACETAMOL ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| FLEXPAR comprimé / 400 mg /500 mg | 🇸🇳Senegal | MEDEOR LIFE CARE LLP | active | — |
| DISTEM 380MG/300MG COMPRIME BOITE DE 50 | 🇨🇮Côte d'Ivoire | CONSULTING PHARMA FORMULATIONS | active | — |
| METHOCARBAMOL +
PARACETAMOL ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| METHOCARBAMOL +
PARACETAMOL ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| METHOCARBAMOL +
PARACETAMOL ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| FLEXPAR comprimé / 400 mg /500 mg | 🇸🇳Senegal | MEDEOR LIFE CARE LLP | active | — |
| DISTEM comprimé / 300 mg / 380 mg | 🇸🇳Senegal | FAES PHARMA | active | — |
| FLEXPRO EXTRA 400MG/500MG COMPRIME PELLICULE BOITE DE 20 | 🇨🇮Côte d'Ivoire | MEDICAL UNION PHARMACEUTICALS (MUP) | active | — |
| FLEXPRO EXTRA comprimé / 400 mg /500 mg | 🇸🇳Senegal | MEDICAL UNION PHARMACEUTICALS (MUP) | active | — |
METHOCARBAMOL + PARACETAMOL in Africa — Regulatory Overview
METHOCARBAMOL + PARACETAMOL is registered across 5 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Uganda, Côte d'Ivoire, Kenya and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.